Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of TNFRSF10A monoclonal antibody, clone 32A1380
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | ICC,WB-Ce,IF,Flow Cyt |
More info about TNFRSF10A monoclonal antibody, clone 32A1380
| Brand: | Abnova |
| Reference: | MAB0054 |
| Product name: | TNFRSF10A monoclonal antibody, clone 32A1380 |
| Product description: | Mouse monoclonal antibody raised against synthetic peptide of TNFRSF10A. |
| Clone: | 32A1380 |
| Isotype: | IgG1 |
| Gene id: | 8797 |
| Gene name: | TNFRSF10A |
| Gene alias: | APO2|CD261|DR4|MGC9365|TRAILR-1|TRAILR1 |
| Gene description: | tumor necrosis factor receptor superfamily, member 10a |
| Immunogen: | A synthetic peptide corresponding to amino acids 1-20 of human TNFRSF10A. |
| Form: | Liquid |
| Recommend dilutions: | The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.05% BSA, 0.05% sodium azide) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis of 15 ug of total cell lysate from Daudi cells with TNFRSF10A monoclonal antibody, clone 32A1380 (Cat # MAB0054) at 2 ug/mL . |
| Applications: | ICC,WB-Ce,IF,Flow Cyt |
| Shipping condition: | Dry Ice |
| Publications: | Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K. Oncogene. 2003 Mar 20;22(11):1653-62. |